17 Feb 2023 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the company's upcoming plans to list on the NASDAQ and provides an update on the its clinical trials.
15 Feb 2023 - The bench-scale test work indicates the alternative process has the potential to improve processing reliability and feed-salt quality, positively impact costs and accelerate production ramp-up.
13 Feb 2023 - Splitit Limited (ASX:SPT) CEO Nandan Sheth discusses the buy now, pay later sector, and Splitit's business model partnerships.
09 Feb 2023 - Sequoia Asset Management Investment Manager Winston Sammut discusses property investment strategy, the impacts of COVID and work from home, shopping malls, industrial property, and alternative property classes.
14 Dec 2022 - RareX Limited (ASX:REE) Managing Director Jeremy Robinson discusses progress at the Cummins Range rare earths project and a potential resource upgrade.
30 November 2022 - James Powell, the General Manager - Investor Relations, Corporate Affairs and Sustainability of the Rural Funds Group Limited (ASX:RFF) presents on the group's FY22 financial results.
28 Nov 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the LAG-3 landscape, the company's portfolio of therapies, encouraging data from the 2022 SITC conference and the outlook for 2023.
25 Nov 2022 - BluGlass Limited (ASX:BLG) President Jim Haden discusses achieving a key reliability milestone for the company's laser diodes.
23 Nov 2022 - Altech Chemicals Limited (ASX:ATC) CFO Martin Stein discusses the recent joint venture with Fraunhofer IKTS and the CERENERGY solid state sodium alumina battery.
22 Nov 2022 - Radiopharmaceutical Theranostics Limited (ASX:RAD) Managing Director and CEO Riccardo Canevari discusses the progress of the company's brain, lung and prostate cancer therapies.
